Evaluation and Management of Asymptomatic Hematuria

Initial Evaluation and Confirmation

The American Academy of Family Physicians recommends that all patients with asymptomatic hematuria require confirmation with microscopic examination (≥3 RBCs/high-power field), followed by exclusion of benign causes, and then a complete urologic evaluation including upper tract imaging and cystoscopy to detect potentially life-threatening malignancies 1, 2
Confirm true hematuria with microscopic urinalysis showing ≥3 red blood cells per high-power field, rather than relying solely on dipstick results 3
Exclude benign transient causes including menstruation, vigorous exercise, sexual activity, trauma, viral illness, and medications 1, 3

Comprehensive urinalysis with sediment examination to determine the number of RBCs/HPF, presence of dysmorphic RBCs (>80% suggests glomerular source), red cell casts, white blood cells, bacteria, and degree of proteinuria 1, 4, 5
Measure serum creatinine to assess renal function 1, 4
Urine cytology is recommended in all patients with risk factors for transitional cell carcinoma (age >40 years, smoking history, occupational chemical/dye exposure, history of pelvic irradiation, irritative voiding symptoms, history of gross hematuria, analgesic abuse) 1, 6, 3

CT urography is the preferred imaging modality for comprehensive evaluation of the upper urinary tract in adults with hematuria 4, 5
Cystoscopy is mandatory in all patients ≥40 years of age and in patients <40 years with risk factors for bladder cancer (smoking, occupational exposures, irritative voiding symptoms, history of gross hematuria) 7, 4

Repeat urinalysis yearly at 6, 12, 24, and 36 months for patients with persistent hematuria after negative urologic workup 2, 7, 4
Monitor blood pressure at each follow-up visit 7, 4
Nephrology referral is indicated if hematuria persists with development of hypertension, proteinuria (>500 mg/24 hours), or evidence of glomerular bleeding (red cell casts, dysmorphic RBCs) 7, 4, 3